Impact of non-dilutive funding on company valuation.
Is it considered best practice to account for significant non-dilutive grant monies in a markup valuation, e.g., in the range of $1.5M - $2.5M?
Is it considered best practice to account for significant non-dilutive grant monies in a markup valuation, e.g., in the range of $1.5M - $2.5M?
Where can I access the form: investor inquiry editor in the left navigation?
Hello, I am trying to send a mass email to all of my prospects for an event. How do I accomplish this with the event template?
this is meant to be a starting point and can evolve it based on our own fund specifics
I need to open a brokerage account for a portco that exited. Will be holding the public stock before distributing to LPs. Should I open the account for the LP or the Manco? I am leaning toward using Fidelity but any recs on best brokerage account for VCs would also be appreciated.
I need to open a brokerage account for a portco that exited. Will be holding the public stock before distributing to LPs. Should I open the account for the LP or the Manco? I am leaning toward using Fidelity but any recs on best brokerage account for VCs would also be appreciated.
Is the landscape shifting towards exit routes like private equity buyouts or secondary markets in the last few years? Should investment strategies change?
I have an angel investment that I have had for several years that is performing well. I would like to promote this as a warehoused deal to prospective LPs. What are the best practices to move this into the fund and can its book value be used towards a GP commit?
Client Alerts Aug. 01, 2024 Delaware Governor Signs Into Law Amendments to Delaware’s General Corporation Law how does the new general corporations law in delaware affects Gps, Mancos or LPs?
I recently had a portfolio company go public. Would like recommendations on best places to hold the shares before distribution to LPs. Do Etrade/Fidelity/Shwab etc allow VC funds to open accounts?
What is the legality behind it. How can we warehouse a deal which was not part of the current fund ?
I no longer have access to introduction page and thesis feedback page. I have not done any sprint. I'm just Lost please what's going on with me. Please help me.
To consolidate the firm structure we are trying to figure out what are the requirements for each role in terms of background, duration of commitment, financial commitment and how many can one have in a firm. Any thoughts or framework on this would be helpful.
I am noticing there are many fees based VP structure popping up. Some start as little as $1k. This is something I found on a form in a VC firm that hasn't closed yet, but they say they have registered and currently run SPVs. "Venture Partners are required to invest a minimum of $5,000, receive incentives for raising capital, gain access and voting rights for our proprietary dealflow and benefit from a elite and diverse network." They have 70 VPs so far. It sounds more of a fee based angel syndicate but with "Venture Partner" titles, as well as a promise for a board seat. Not sure how that's possible with their check size between $100k-200K
A small startup studio fund can get crammed down if and when future rounds are needed. Some innovative methods to protect the fund's interest without sabotaging future funding would be useful to have.
There's obviously pro-rata considerations which I think provide a floor, but beyond that, what other considerations should we be thinking about?
This is for portfolio construction modeling and some assumptions that we're making.
Lots of GPs I talk to mention they are basically equivalent, Decile Hub didn't give me much context on this either.
Fund I has no reserves and is investing in Seed stage. In future, I hope to establish a Fund II with follow-on reserves, investing in Seed plus Series A. If I get pro rata rights from my investments in Fund I, can I use those rights to invest using the new Fund II?
This question came up as it tied together several common themes, including the overall success rate of emerging funds (i.e, a fund that failed will not reach profitability), fund model between distributed/concentrated/hybrid, capital deployment, and liquidity events. At the same time, emerging funds have shown the ability to outperform, so I would love to learn more about when they are able to reach profitability and greatly reduce risk while retaining upside.
Regarding vesting schedules, % of the company, Key People considered, at which point in the startup's development it should be defined.
• Investment Valuations: • Common valuation methods and update frequencies. • Impact on financial statements and documentation requirements.
I have been doing a lot of research and can't seem to find any Canadian equivalents to Angelist, Carta, and Sydecar. Brightspark Capital utilizes SPVs, and I know they are creating a beta SPV product, but it's currently not released publicly. I am based out of Toronto, and aiming to invest in mostly Canadian & US startups. I wanted to do syndicates to help build up the track record, but again, I've been struggling to find a provider here in Canada. If anyone has any leads for a provider, let me know!
Does anyone has an advise for a portfolio / account management company in Europe, specifically in the Netherlands?